Clinical Trial Update: Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

This entry describes an ongoing Phase 3 clinical trial comparing maintenance therapy with toripalimab plus capecitabine versus capecitabine alone for high-risk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Jiangxi Provincial Cancer Hospital | Conditions: Nasopharyngeal Carcinoma, High-Risk Cancer | Phase 3 | Status: RECRUITING